Literature DB >> 685887

Review of existing vaccines for influenza.

H M Meyer, H E Hopps, P D Parkman, F A Ennis.   

Abstract

The problems of producing and distributing influenza vaccines are described as well as effectiveness and adverse reactions. It appears that Guillain-Barré (GBS) is likely to be encountered with the use of any of the inactivated influenza vaccines.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 685887

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


  8 in total

1.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Authors:  M L Clements; S O'Donnell; M M Levine; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

4.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

5.  The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.

Authors:  Edwin D Kilbourne; Catherine Smith; Ian Brett; Barbara A Pokorny; Bert Johansson; Nancy Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

6.  Immunogenicity of a viral model vaccine after different inactivation procedures.

Authors:  M F Bachmann; C Bast; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

7.  Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses.

Authors:  M F Bachmann; T M Kündig; C P Kalberer; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 8.  Viral-bacterial synergistic interaction in respiratory disease.

Authors:  L A Babiuk; M J Lawman; H B Ohmann
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.